Literature DB >> 9016641

Phosphorylation of ATF-1 enhances its DNA binding and transcription of the Na,K-ATPase alpha 1 subunit gene promoter.

M Kobayashi1, A Shimomura, M Hagiwara, K Kawakami.   

Abstract

Transcriptional activity of both ATF-1 and CREB is enhanced by protein phosphorylation. While enhancement has been attributed to an increase in binding affinity for a co-activator (CBP), induction of the DNA binding activity by phosphorylation is an open question. Using the Na,K-ATPase alpha1 subunit gene promoter, which has an asymmetrical ATF/CRE site, we analyzed the effect of phosphorylation on DNA binding activity of the ATF-1-CREB heterodimer. Dephosphorylation of the heterodimer in nuclear extracts reduced binding to the ATF/CRE site. Phosphorylation of ATF-1 at Ser63 enhanced its binding to the ATF/CRE site in both the homodimeric and heterodimeric forms. Transcription of the Na,K-ATPase alpha 1 subunit gene promoter was also stimulated by phosphorylated ATF-1 in vitro.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9016641      PMCID: PMC146500          DOI: 10.1093/nar/25.4.877

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  37 in total

1.  Phosphorylation of cellular proteins regulates their binding to the cAMP response element.

Authors:  A Merino; L Buckbinder; F H Mermelstein; D Reinberg
Journal:  J Biol Chem       Date:  1989-12-15       Impact factor: 5.157

2.  Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133.

Authors:  G A Gonzalez; M R Montminy
Journal:  Cell       Date:  1989-11-17       Impact factor: 41.582

3.  Identification and purification of a human immunoglobulin-enhancer-binding protein (NF-kappa B) that activates transcription from a human immunodeficiency virus type 1 promoter in vitro.

Authors:  K Kawakami; C Scheidereit; R G Roeder
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

4.  Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB.

Authors:  K K Yamamoto; G A Gonzalez; W H Biggs; M R Montminy
Journal:  Nature       Date:  1988-08-11       Impact factor: 49.962

5.  Calmodulin-dependent protein kinase II potentiates transcriptional activation through activating transcription factor 1 but not cAMP response element-binding protein.

Authors:  A Shimomura; Y Ogawa; T Kitani; H Fujisawa; M Hagiwara
Journal:  J Biol Chem       Date:  1996-07-26       Impact factor: 5.157

6.  A unique enhancer element for the trans activator (p40tax) of human T-cell leukemia virus type I that is distinct from cyclic AMP- and 12-O-tetradecanoylphorbol-13-acetate-responsive elements.

Authors:  J Fujisawa; M Toita; M Yoshida
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

7.  Human beta-polymerase gene. Structure of the 5'-flanking region and active promoter.

Authors:  S G Widen; P Kedar; S H Wilson
Journal:  J Biol Chem       Date:  1988-11-15       Impact factor: 5.157

8.  HTLV-I tax gene product activates transcription via pre-existing cellular factors and cAMP responsive element.

Authors:  C Z Giam; Y L Xu
Journal:  J Biol Chem       Date:  1989-09-15       Impact factor: 5.157

9.  Identification of basal and cyclic AMP regulatory elements in the promoter of the phosphoenolpyruvate carboxykinase gene.

Authors:  P G Quinn; T W Wong; M A Magnuson; J B Shabb; D K Granner
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

10.  A cellular transcription factor E4F1 interacts with an E1a-inducible enhancer and mediates constitutive enhancer function in vitro.

Authors:  K A Lee; M R Green
Journal:  EMBO J       Date:  1987-05       Impact factor: 11.598

View more
  8 in total

1.  Interrogating cAMP-dependent kinase signaling in Jurkat T cells via a protein kinase A targeted immune-precipitation phosphoproteomics approach.

Authors:  Piero Giansanti; Matthew P Stokes; Jeffrey C Silva; Arjen Scholten; Albert J R Heck
Journal:  Mol Cell Proteomics       Date:  2013-07-23       Impact factor: 5.911

2.  Transcriptional activity of neural retina leucine zipper (Nrl) is regulated by c-Jun N-terminal kinase and Tip60 during retina development.

Authors:  Jung-Woong Kim; Sang-Min Jang; Chul-Hong Kim; Joo-Hee An; Kyung-Hee Choi
Journal:  Mol Cell Biol       Date:  2012-02-21       Impact factor: 4.272

3.  Cyclin A is a mediator of p120E4F-dependent cell cycle arrest in G1.

Authors:  L Fajas; C Paul; A Vié; S Estrach; R Medema; J M Blanchard; C Sardet; M L Vignais
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

4.  Varicella-Zoster Virus Activates CREB, and Inhibition of the pCREB-p300/CBP Interaction Inhibits Viral Replication In Vitro and Skin Pathogenesis In Vivo.

Authors:  Sylvie François; Nandini Sen; Bryan Mitton; Xiangshu Xiao; Kathleen M Sakamoto; Ann Arvin
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

5.  Regulation of the Mts1-Mts2-dependent ade6-M26 meiotic recombination hot spot and developmental decisions by the Spc1 mitogen-activated protein kinase of fission yeast.

Authors:  N Kon; S C Schroeder; M D Krawchuk; W P Wahls
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

6.  The protein level and transcription activity of activating transcription factor 1 is regulated by prolyl isomerase Pin1 in nasopharyngeal carcinoma progression.

Authors:  Guo-Liang Huang; Dan Liao; Hua Chen; Yan Lu; Liyong Chen; Huahui Li; Binbin Li; Weilong Liu; Caiguo Ye; Tong Li; Zhu Zhu; Jian Wang; Takafumi Uchida; Ying Zou; Zigang Dong; Zhiwei He
Journal:  Cell Death Dis       Date:  2016-12-29       Impact factor: 8.469

Review 7.  Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function.

Authors:  Selena Vigano; Dimitrios Alatzoglou; Melita Irving; Christine Ménétrier-Caux; Christophe Caux; Pedro Romero; George Coukos
Journal:  Front Immunol       Date:  2019-06-06       Impact factor: 7.561

Review 8.  Transcriptional regulators of Na,K-ATPase subunits.

Authors:  Zhiqin Li; Sigrid A Langhans
Journal:  Front Cell Dev Biol       Date:  2015-10-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.